Clinical Trial Update: Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP [Phase 3]

View source ↗

Summary

A Phase 3 comparative study comparing GNR-069 with Nplate for efficacy and safety in idiopathic thrombocytopenic purpura has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura

Drugs mentioned

• GNR-069
• Nplate (romiplostim)

Snippet

Sponsor: AO GENERIUM | Conditions: Idiopathic Thrombocytopenic Purpura | Phase 3 | Status: COMPLETED